Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 32
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Cummings, J.L. and Zhong, K. 2016. Developing Therapeutics for Alzheimer's Disease.

    Henneges, Carsten Reed, Catherine Chen, Yun-Fei Dell’Agnello, Grazia Lebrec, Jeremie and Galimberti, Daniela 2016. Describing the Sequence of Cognitive Decline in Alzheimer’s Disease Patients: Results from an Observational Study. Journal of Alzheimer's Disease, Vol. 52, Issue. 3, p. 1065.

    Bishop, Kathleen M. Hogan, Mary Janicki, Matthew P. Keller, Seth M. Lucchino, Ronald Mughal, Dawna T. Perkins, Elizabeth A. Singh, Baldev K. Service, Kathy and Wolfson, Sarah 2015. Guidelines for Dementia-Related Health Advocacy for Adults With Intellectual Disability and Dementia: National Task Group on Intellectual Disabilities and Dementia Practices. Intellectual and Developmental Disabilities, Vol. 53, Issue. 1, p. 2.

    Cohen, M. L. Kim, C. Haldiman, T. ElHag, M. Mehndiratta, P. Pichet, T. Lissemore, F. Shea, M. Cohen, Y. Chen, W. Blevins, J. Appleby, B. S. Surewicz, K. Surewicz, W. K. Sajatovic, M. Tatsuoka, C. Zhang, S. Mayo, P. Butkiewicz, M. Haines, J. L. Lerner, A. J. and Safar, J. G. 2015. Rapidly progressive Alzheimer's disease features distinct structures of amyloid- . Brain, Vol. 138, Issue. 4, p. 1009.

    Hochstetler, Helen Trzepacz, Paula T. Wang, Shufang Yu, Peng Case, Michael Henley, David B. Degenhardt, Elisabeth Leoutsakos, Jeannie-Marie Lyketsos, Constantine G. and Adamson, Maheen Mausoof 2015. Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline. Journal of Alzheimer's Disease, Vol. 50, Issue. 1, p. 271.

    Schmidt, Christian Gerlach, Nicole Schmitz, Matthias Thom, Tobias Kramer, Katharina Friede, Tim and Zerr, Inga 2015. Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer’s Disease. Journal of Alzheimer's Disease, Vol. 48, Issue. 1, p. 189.

    Castro-Costa, Érico Dewey, Michael E. Uchôa, Elizabeth Firmo, Josélia O. A. Lima-Costa, Maria Fernanda and Stewart, Robert 2014. Construct validity of the mini mental state examination across time in a sample with low-education levels: 10-year follow-up of the Bambuí Cohort Study of Ageing. International Journal of Geriatric Psychiatry, Vol. 29, Issue. 12, p. 1294.

    Kabir, M Enamul and Safar, Jiri G 2014. Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases. Prion, Vol. 8, Issue. 1, p. 111.

    Koppel, Jeremy Acker, Chris Davies, Peter Lopez, Oscar L. Jimenez, Heidy Azose, Miriam Greenwald, Blaine S. Murray, Patrick S. Kirkwood, Caitlin M. Kofler, Julia and Sweet, Robert A. 2014. Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities. Neurobiology of Aging, Vol. 35, Issue. 9, p. 2021.

    Li, Xiao-Ling Hu, Nan Tan, Meng-Shan Yu, Jin-Tai and Tan, Lan 2014. Behavioral and Psychological Symptoms in Alzheimer’s Disease. BioMed Research International, Vol. 2014, p. 1.

    Murray, Patrick S. Kumar, Sanjeev DeMichele-Sweet, Mary Ann A. and Sweet, Robert A. 2014. Psychosis in Alzheimer’s Disease. Biological Psychiatry, Vol. 75, Issue. 7, p. 542.

    Schmidt, Christian Becker, Harry Peter, Christoph Lange, Katharina Friede, Tim and Zerr, Inga 2014. Plasma prion protein concentration and progression of Alzheimer disease. Prion, Vol. 8, Issue. 2, p. 210.

    Schmidt, Christian Wolff, Martin von Ahsen, Nicolas Lange, Katharina Friede, Tim and Zerr, Inga 2014. CR1 is potentially associated with rate of decline in sporadic Alzheimer’s disease. Journal of Clinical Neuroscience, Vol. 21, Issue. 10, p. 1705.

    Vatsavayi, Anil Varma V. Kofler, Julia DeMichele-Sweet, Mary Ann A. Murray, Patrick S. Lopez, Oscar L. and Sweet, Robert A. 2014. TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis. International Psychogeriatrics, Vol. 26, Issue. 06, p. 987.

    Canevelli, Marco Adali, Nawal Voisin, Thierry Soto, Maria Eugenia Bruno, Giuseppe Cesari, Matteo and Vellas, Bruno 2013. Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory. International Journal of Geriatric Psychiatry, Vol. 28, Issue. 8, p. 795.

    Canevelli, Marco Adali, Nawal Cantet, Christelle Andrieu, Sandrine Bruno, Giuseppe Cesari, Matteo and Vellas, Bruno 2013. Impact of behavioral subsyndromes on cognitive decline in Alzheimer’s disease: data from the ICTUS study. Journal of Neurology, Vol. 260, Issue. 7, p. 1859.

    Jokinen, Nancy Janicki, Matthew P. Keller, Seth M. McCallion, Philip and Force, Lawrence T. 2013. Guidelines for Structuring Community Care and Supports for People With Intellectual Disabilities Affected by Dementia. Journal of Policy and Practice in Intellectual Disabilities, Vol. 10, Issue. 1, p. 1.

    Köhler, Sebastian Allardyce, Judith Verhey, Frans R.J. McKeith, Ian G. Matthews, Fiona Brayne, Carol and Savva, George M. 2013. Cognitive Decline and Dementia Risk in Older Adults With Psychotic Symptoms: A Prospective Cohort Study. The American Journal of Geriatric Psychiatry, Vol. 21, Issue. 2, p. 119.

    Pillai, Jagan A. and Cummings, Jeffrey L. 2013. Clinical Trials in Predementia Stages of Alzheimer Disease. Medical Clinics of North America, Vol. 97, Issue. 3, p. 439.

    Waldrop, Deborah and Kutner, Jean S. 2013. Evidence-Based Practice in Palliative Medicine.


Trajectories of cognitive decline in Alzheimer's disease

  • Patricia A. Wilkosz (a1), Howard J. Seltman (a2), Bernie Devlin (a1), Elise A. Weamer (a1) (a3), Oscar L. Lopez (a1) (a3), Steven T. DeKosky (a1) (a3) and Robert A. Sweet (a1) (a3) (a4)
  • DOI:
  • Published online: 28 September 2009

Background: Late-onset Alzheimer disease (LOAD) is a clinically heterogeneous complex disease defined by progressively disabling cognitive impairment. Psychotic symptoms which affect approximately one-half of LOAD subjects have been associated with more rapid cognitive decline. However, the variety of cognitive trajectories in LOAD, and their correlates, have not been well defined. We therefore used latent class modeling to characterize trajectories of cognitive and behavioral decline in a cohort of AD subjects.

Methods: 201 Caucasian subjects with possible or probable Alzheimer's disease (AD) were evaluated for cognitive and psychotic symptoms at regular intervals for up to 13.5 years. Cognitive symptoms were evaluated serially with the Mini-mental State Examination (MMSE), and psychotic symptoms were rated using the CERAD behavioral rating scale (CBRS). Analyses undertaken were latent class mixture models of quadratic trajectories including a random intercept with initial MMSE score, age, gender, education, and APOE ϵ4 count modeled as concomitant variables. In a secondary analysis, psychosis status was also included.

Results: AD subjects showed six trajectories with significantly different courses and rates of cognitive decline. The concomitant variables included in the best latent class trajectory model were initial MMSE and age. Greater burden of psychotic symptoms increased the probability of following a trajectory of more rapid cognitive decline in all age and initial MMSE groups. APOE ϵ4 was not associated with any trajectory.

Conclusion: Trajectory modeling of longitudinal cognitive and behavioral data may provide enhanced resolution of phenotypic variation in AD.

Corresponding author
Correspondence should be addressed to: Robert A. Sweet, M. D., Professor of Psychiatry and Neurology, University of Pittsburgh, Biomedical Science Tower, Rm W-1645, 3811 O'Hara Street, Pittsburgh, PA 15213–2593, U.S.A. Phone +1 412 383 8548; Fax +1 412 624 9910. Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

S. A. Bacanu , B. Devlin , K. V. Chowdari , S. T. DeKosky , V. L. Nimgaonkar and R. A. Sweet (2005). Heritability of psychosis in Alzheimer disease. American Journal of Geriatric Psychiatry, 13, 624627.

L. L. Barnes , R. S. Wilson , J. A. Schneider , J. L. Bienias , D. A. Evans and D. A. Bennett (2003). Gender, cognitive decline, and risk of AD in older persons. Neurology, 60, 17771781.

L. Berg (1998). Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Archives of Neurology, 55, 326335.

K. Bertram , M. B. McQueen , K. Mullin , D. Blacker and R. E. Tanzi (2007). Systematic Meta-Analysis of Alzheimer Disease Genetic Association Studies: The AlzGene Database. Nature Genetics, 39, 1723.

P. Bretsky , J. M. Guralnik , L. Launer , M. Albert and T. E. Seeman (2003). The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology, 60, 10771081.

E. H. Corder (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921923.

S. Craft (1998). Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology, 51, 149153.

H. H. Dodge , Y. Du , J. A. Saxton and M. Ganguli (2006). Cognitive domains and trajectories of functional independence in nondemented elderly persons. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 61, 13301337.

M. F. Folstein , S. E. Folstein and P. R. McHugh (1975). Mini mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.

D. G. Healy (2006). Case-control studies in the genomic era: a clinician's guide. Lancet Neurology, 5, 701707.

V. S. Helgeson , P. Snyder and H. Seltman (2004). Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychology, 23, 315.

P. Hollingworth (2007). Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B, 841848.

P. Holmans (2005). Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 135B, 2432.

B. D. Hoyt , P. J. Massman , C. Schatschneider , N. Cooke and R. S. Doody (2005). Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Archives of Neurology, 62, 454459.

B. L. Jones , D. S. Nagin and K. Roeder (2001). A SAS procedure based on mixture models for estimating developmental trajectories. Sociological Methods and Research, 29, 374393.

M. I. Kamboh , C. E. Aston and R. F. Hamman (1995). The relationship of APOE polymorphism and cholesteral levels in normoglycemic and diabetic subjects in biethnic population from the San Luis Valley, Colorado. Atherosclerosis, 112, 145159.

T. Kleiman (2006). Apolipoprotein E ϵ4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Dementia and Geriatric Cognitive Disorders, 22, 7382.

E. Leisch (2004). FlexMix: a general framework for finite mixture models and latent class regression in R. Journal of Statistical Software, 11, 118.

O. L. Lopez , L. H. Kuller , A. Fitzpatrick , D. Ives , J. T. Becker and N. Beauchamp (2003). Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology, 22, 112.

U. M. Mann , E. Mohr , M. Gearing and T. N. Chase (1992). Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. Journal of Neurology, Neurosurgery and Psychiatry, 55, 956959.

C. A. Martins , A. Oulhaj , C. A. de Jager and J. H. Williams (2005). APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology, 65, 18881893.

I. G. McKeith (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47, 11131124.

G. McKhann , D. Drachman , M. Folstein , R. Katzman , D. Price and E. M. Stadlan (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939944.

R. O'Hara , B. Sommer , N. Way , H. C. Kraemer , J. Taylor and G. Murphy (2008). Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein ϵ4 allele. Journal of Psychiatric Research, 42, 199204.

D. X. Rasmusson , K. A. Carson , R. Brookmeyer , C. Kawas and J. Brandt (1996). Predicting rate of cognitive decline in probable Alzheimer's disease. Brain and Cognition, 31, 133147.

S. A. Ropacki and D. V. Jeste (2005). Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. American Journal of Psychiatry, 162, 20222030.

N. Scarmeas (2005). Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology, 62, 16011608.

G. Schwarz (1978). Estimating the dimension of a model. Annals of Statistics, 6, 461464.

S. L. Tyas (2007). Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. American Journal of Epidemiology, 165, 12311238.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *